RxCap, Inc. — Form D
RxCap, Inc. of LYNNFIELD, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-05-06. The offering totals $21.2M, of which $19.7M was reported sold. Industry: Other Technology.
Offering
- Filed: 2024-05-06
- Form: D
- Accession: 0002021904-24-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $21.2M
- Amount sold: $19.7M
- Remaining: $1.5M
- Investors: 22
- Date of first sale: 2024-04-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-512448
Issuer
- Name: RxCap, Inc.
- CIK: 0002021904
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 14 RUSSET LANE, LYNNFIELD, MA, 01940
- Phone: 415-254-7090
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Will Shrank | Director | New Orleans, LA |
| John Rea | Director | LYNNFIELD, MA |
| Toby Haba | Director | LYNNFIELD, MA |
| Mike Furlotti | Director | LYNNFIELD, MA |
| Sreeram Ramakrishnan | Director | LYNNFIELD, MA |
| Sreeram Ramakrishnan | Executive Officer | LYNNFIELD, MA |
Other filings by this issuer (1)
More